2024 Platinum-etoposide chemotherapy

Platinum-etoposide chemotherapy

Author: fjqp

August undefined, 2024

Webb2 feb. 2024 · Poorly differentiated neuroendocrine carcinomas account for 7–21% of digestive neuroendocrine neoplasms. , Platinum–etoposide chemotherapy is the first …

Etoposide and cisplatin chemotherapy (EP) Macmillan Cancer Support

WebbEtoposide and cisplatin chemotherapy (EP) is a combination chemotherapy treatment used to treat different types of cancer. It is best to read this information with our general … Webb13 juni 2024 · Based on this Phase II randomised trial, phased ipilimumab was investigated in the following Phase III study. 18 In this trial, 1,132 patients were assigned to a platinum/etoposide regimen for 4–6 cycles plus phased ipilimumab 10 mg/kg or placebo every 3 weeks followed by a maintenance phase of ipilimumab 10 mg/kg or placebo … うぶらぶダンス

Bevacizumab plus FOLFIRI after failure of platinum–etoposide …

Webb8 apr. 2024 · In keeping with this, treatment of metastatic disease with platinum-etoposide chemotherapy mirrors small-cell lung cancer treatment recommendations. However, clinical course and best treatment strategy are far from being clear. Webb1 juli 2024 · Currently, programmed death-ligand 1 (PD-L1) inhibitor plus platinum-etoposide chemotherapy has been recognized as a standard treatment for patients with … Webb20 jan. 2005 · Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose … うぶらぶアイランドストア曲

Cancers Free Full-Text Total Metabolic Tumor Volume on 18F …

Webb28 okt. 2024 · Although 74% of the patients in the atezolizumab group had received previous 1L cycle of platinum-etoposide treatment (21% being cisplatin-etoposide), the mOS was not statistically different in those who received cisplatin-etoposide versus carboplatin-etoposide chemotherapy (mOS = 9.8 versus 13.3 mo, p = 0.21). Radiation … Webb20 mars 2024 · Platinum-based anticancer drugs, including cisplatin, carboplatin, oxaliplatin, nedaplatin, and lobaplatin, are heavily applied in chemotherapy regimens. … うぶらぶコード簡単Webb11 apr. 2024 · Platinum-based chemotherapy has been the standard first-line treatment for both limited-stage (LS) and extensive-stage (ES) disease since the 1980s, with an objective response rate (ORR) of about 65% and a one-year survival rate of 30%-40% for ES-SCLC ( … palenica live

"Webb8 okt. 2024 · Background: Etoposide plus platinum-based chemotherapy (EP) was the first-line (1L) extensive stage small cell lung cancer (ES-SCLC) standard of care for many years. 1L treatment with immunotherapy (durvalumab or atezolizumab) combined with carboplatin (durvalumab, atezolizumab) or cisplatin (durvalumab) chemotherapy (CT) is … " - Platinum-etoposide chemotherapy

Platinum-etoposide chemotherapy

Webb1 nov. 2024 · With platinum and etoposide (PE) chemotherapy combination in extensive disease the median progression-free survival (PFS) is only 5.5 months and the median overall survival (OS) under 10 months . These figures underline the need to optimise … WebbThe dose-reduced chemotherapy with first-line etoposide plus platinum had non-inferior survival outcomes compared to the full-dose chemotherapy in elderly patients with ED …

Did you know?

Webb11 apr. 2024 · All patients received platin-based chemotherapy with either carboplatin or cisplatin together with etoposide. At least one cycle of atezolizumab or durvalumab was administered, in most cases from the second or third cycle onwards. Immunotherapy with PD-L1 inhibitors was discontinued in case of adverse effects or disease progression. Webb10 apr. 2024 · Patients were eligible if they had: (i) biopsy-proven SCLC, (ii) stage IV disease, or (iii) treatment with platinum-etoposide chemotherapy alone (CT group) or in association with first-line PD-L1 inhibitors, atezolizumab, or durvalumab (CIT group).

Webb5 dec. 2024 · Prospective evaluation of the effect on initial brain metastases from small cell lung cancer of platinum-etoposide based induction chemotherapy followed by an alternating multidrug regimen. Ann Oncol 1993; 4:579. Twelves CJ, Souhami RL, Harper PG, et al. The response of cerebral metastases in small cell lung cancer to systemic … WebbUntil June, 2024, topotecan was the only approved drug for patients with sensitive relapsed small-cell lung cancer who progressed after platinum-based chemotherapy. Topotecan …

Webb8 apr. 2024 · Interestingly, the administration of perioperative chemotherapy (either neoadjuvant or adjuvant platinum-based doublet with etoposide) showed a non … Webb27 okt. 2024 · Of the 34 patients who received atezolizumab, 24% had Eastern Cooperative Oncology Group performance status greater than or equal to 2, approximately 50% were …

Webb23 nov. 2024 · Platinum-etoposide consisted of etoposide 80-100 mg/m2on days 1-3 of each cycle with investigator's choice of either carboplatin area under the curve 5-6 …

Webb11 apr. 2024 · BackgroundThere are a variety of treatment options for recurrent platinum-resistant ovarian cancer, and the optimal specific treatment still remains to be determined. Therefore, this Bayesian network meta-analysis was conducted to investigate the optimal treatment options for recurrent platinum-resistant ovarian cancer.MethodsPubmed, … palenica mocenokWebb18 juli 2024 · For over 30 years, platinum-based chemotherapy has remained the primary therapeutic option for patients with SCLC. The recent CASPIAN and IMpower133 studies on the effectiveness of the combination of chemotherapy and immunotherapy in this group of patients have opened a completely new chapter in SCLC treatment. palenica nartyWebb8 mars 2024 · Historically, cytotoxic chemotherapy consisting of platinum–etoposide or anthracycline-based regimens has demonstrated a high response rate, but early chemoresistance leads to a poor prognosis in advanced SCLC. Only a fraction of patients with limited-disease can be cured by chemo-radiotherapy. palenica noclegiWebbAdjuvant chemotherapy with a platinum/etoposide-containing regimen should be used in women with metastatic disease. All 5 women with ETT in this series were cured using … うぶらぶピアノ簡単Webb6 juli 2024 · Phase II Trial of Platinum-Etoposide Chemotherapy and Durvalumab (MEDI4736) With Sub-Ablative SBRT in Patients With Newly Diagnosed Stage IV Small … うぶらぶなにわ曲歌詞Webb28 feb. 2024 · In recent years, programmed cell death-ligand 1 (PD-L1) inhibitor plus platinum-etoposide chemotherapy was found to have favorable clinical outcomes in patients with extensive-stage SCLC (ES-SCLC). The usefulness of early tumor shrinkage (ETS) has been reported in various types of cancers. palenica rosinaWebbSafety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung disease The combination of platinum agents plus etoposide … うぶらぶなにわ歌詞ひらがな